Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Omalizumab
(Xolair (TN))		[1] Omalizumab (Xolair PFS)[1] Omalizumab (Xolair (TN)) 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[7] 46, 53, 65, 98, 162, 226, 299 💬
2Omalizumab (Xolair)[1] Omalizumab (Xolair PFS)[1] Omalizumab (Xolair (TN)) 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 65 💬
3Recombinant humanized monoclonal antibody omalizumab to IgE
(Xolair (TN))		[1] Omalizumab (Xolair PFS)[1] Omalizumab (Xolair (TN)) 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 299 💬
4Rituximab combined with Omalizumab
(Xolair (TN))		[2] Omalizumab (Xolair PFS),
Rituximab		[2] Rituximab ,
Omalizumab (Xolair (TN)) 💬 		[2] FCER1A,
MS4A1 💬 		[5] Asthma, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 162 💬
5Xolair[1] Omalizumab (Xolair PFS)[1] Omalizumab (Xolair (TN)) 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[2] 46, 299 💬
6Xolair 150 mg Pulver und Injektionslösung zur Herstellung einer Injektionslösung[1] Omalizumab (Xolair PFS)[1] Omalizumab (Xolair (TN)) 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 299 💬